Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommy F Liu

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2006
Web resources for HIV type 1 genotypic-resistance test interpretationTommy F Liu, Robert W Shafer
Intervirology|January 31, 2012
The HIVdb system for HIV-1 genotypic resistance interpretationMichele W Tang, Tommy F Liu, Robert W Shafer
Plos Computational Biology|May 16, 2007
HIV-1 subtype B protease and reverse transcriptase amino acid covariationSoo-Yon Rhee, Tommy F Liu, Susan P Holmes, et al.
The Journal of Infectious Diseases|October 24, 2007
Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatmentYumi Mitsuya, Tommy F Liu, Soo-Yon Rhee, et al.
AIDS Research and Human Retroviruses|October 22, 2010
HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravirVici Varghese, Tommy F Liu, Soo-Yon Rhee, et al.
Plos One|August 21, 2014
Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencingSeverine Margeridon-Thermet, Sophie Le Pogam, Lewyn Li, et al.
Bioinformatics (Oxford, England)|March 24, 2009
The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistanceRobert J Gifford, Tommy F Liu, Soo-Yon Rhee, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2012
Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistanceFarbod Babrzadeh, Vici Varghese, Mary Pacold, et al.
Retrovirology|August 9, 2008
Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitorsSoo-Yon Rhee, Tommy F Liu, Mark Kiuchi, et al.
AIDS (London, England)|March 22, 2008
Sequence editing by Apolipoprotein B RNA-editing catalytic component [corrected] and epidemiological surveillance of transmitted HIV-1 drug resistanceRobert J Gifford, Soo-Yon Rhee, Nicolas Eriksson, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2006
Web resources for HIV type 1 genotypic-resistance test interpretationTommy F Liu, Robert W Shafer
Intervirology|January 31, 2012
The HIVdb system for HIV-1 genotypic resistance interpretationMichele W Tang, Tommy F Liu, Robert W Shafer
Plos Computational Biology|May 16, 2007
HIV-1 subtype B protease and reverse transcriptase amino acid covariationSoo-Yon Rhee, Tommy F Liu, Susan P Holmes, et al.
The Journal of Infectious Diseases|October 24, 2007
Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatmentYumi Mitsuya, Tommy F Liu, Soo-Yon Rhee, et al.
AIDS Research and Human Retroviruses|October 22, 2010
HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravirVici Varghese, Tommy F Liu, Soo-Yon Rhee, et al.
Plos One|August 21, 2014
Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencingSeverine Margeridon-Thermet, Sophie Le Pogam, Lewyn Li, et al.
Bioinformatics (Oxford, England)|March 24, 2009
The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistanceRobert J Gifford, Tommy F Liu, Soo-Yon Rhee, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2012
Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistanceFarbod Babrzadeh, Vici Varghese, Mary Pacold, et al.
Retrovirology|August 9, 2008
Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitorsSoo-Yon Rhee, Tommy F Liu, Mark Kiuchi, et al.
AIDS (London, England)|March 22, 2008
Sequence editing by Apolipoprotein B RNA-editing catalytic component [corrected] and epidemiological surveillance of transmitted HIV-1 drug resistanceRobert J Gifford, Soo-Yon Rhee, Nicolas Eriksson, et al.
Pageof 3